呼吸道病原体检测不能预测门诊腺样体扁桃体切除术后风险
这项前瞻性双盲队列研究对164例接受门诊腺样体切除术/扁桃体切除术的患儿术中采集鼻咽拭子,用PCR检测22种已知上呼吸道感染病原体(含SARS-CoV-2),结果显示82.9%的患儿检出至少一种病原体,但感染组与未感染组在非计划入院、PACU停留时间及术中术后不良事件上均无显著差异。
要点
- 门诊腺样体/扁桃体切除术前不建议常规进行上呼吸道病原体检测。
- 近期上呼吸道病原体检测阳性不应作为推迟手术的依据。
- 健康患儿术中检出上呼吸道病原体不增加术中及术后风险。
核心结论
- 在健康患儿中,近期上呼吸道感染检测阳性并不增加门诊腺样体切除术/扁桃体切除术的术中或术后风险。
- 术前上呼吸道感染检测没有实用价值,因近期检测阳性而推迟手术在该人群中并不合理。
研究设计与样本
- 前瞻性双盲队列研究,共纳入164例接受门诊腺样体切除术/扁桃体切除术(伴或不伴鼓膜置管)的患儿。
- 术中采集鼻咽拭子,采用PCR检测22种已知上呼吸道感染病原体,包括SARS-CoV-2,外科医生与家属对结果设盲。
- 患儿年龄8个月至18岁,男女各占50%。
主要发现
- 164例患儿中136例(82.9%)术中检出一种或以上上呼吸道病原体。
- 无患儿SARS-CoV-2检测阳性。
- 感染组与未感染组在入院率、PACU停留时间、喉痉挛/支气管痉挛、血氧饱和度下降、心动过缓及术后急诊就诊率上均无显著差异。
临床怎么用
- 健康患儿行门诊腺样体切除术/扁桃体切除术时,可不因近期上呼吸道感染检测阳性而推迟手术。
- 术前常规上呼吸道病原体检测在该人群中缺乏应用价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: To determine whether the presence of detectable upper respiratory infections (URIs) at the time of adenoidectomy/adenotonsillectomy is associated with increased morbidity, complications, and unexpected admissions. STUDY DESIGN: Prospective double-blinded cohort. METHODS: In this prospective cohort study, nasopharyngeal swabs were obtained intraoperatively from 164 pediatric patients undergoing outpatient adenoidectomy/tonsillectomy with or without pressure equalization tubes (PETs) and were analyzed with PCR for the presence of 22 known URIs, including SARS-CoV-2. Surgeons and families were blinded to the results. At the conclusion of the study, rates of detectable infection were determined and intraoperative and postoperative events (unexpected admissions, length of PACU stay, rates of laryngospasm/bronchospasm, oxygen desaturation, bradycardia, and postoperative presentation to an emergency department) were compared between infected and uninfected patients. RESULTS: Of the 164 patients (50% male, 50% female, ages 8 mo-18 y), 136 patients (82.9%) tested positive for one or more URI at the time of surgery. Forty one patients (25.0%) tested positive for three or more URIs concurrently, and 11 (6.7%) tested positive for five or more URIs concurrently. There were no significant differences in admission rates, length of PACU stay, rates of laryngospasm/bronchospasm, oxygen desaturation, bradycardia, or postoperative presentation to an emergency department between positive and negative patients. No patients tested positive for SARS-CoV-2. CONCLUSIONS: A recent positive URI test does not confer any additional intraoperative or postoperative risk in the setting of outpatient adenoidectomy/tonsillectomy in healthy patients. There is no utility in preoperative URI testing, and delaying surgery due to a recent positive URI test is not warranted in this population. LEVEL OF EVIDENCE: 3 Laryngoscope, 131:E2074-E2079, 2021.
引用
- Vickers DM, Reddy A, Akmyradov C, et al. Detection of Respiratory Pathogens Does Not Predict Risks After Outpatient Adenotonsillectomy. Laryngoscope. 2020. PMID: 33150974. doi:10.1002/lary.29236
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。